SEC Company Response from Propanc Biopharma, Inc. (PPCB) (CIK 0001517681) (PPCB) — Dec 13, 2011
Propanc Biopharma, Inc. (PPCB) (CIK 0001517681)
Date: Dec. 13, 2011 · CIK: 0001517681 · Accession: 0001354488-11-004982
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-175092
Letter
VIA EDGAR Division of Corporation Finance Re: Propanc Health Group Corporation Registration Statement on Form S-1, as amended, initially filed on June 23, 2011 (the “Registration Statement”) File No: 333-175092
Dear Mr. Krug:
Propanc Health Group Corporation (the “Company”) hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:30 p.m., Thursday, December 15, 2011, or as soon thereafter as practicable.
In connection with our request, we acknowledge the following:
· Should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal laws of the United States.
Thank you in advance for your attention to this matter.
Very truly yours,
Propanc Health Group Corporation
Show Raw Text
CORRESP
1
filename1.htm
prop_corresp.htm
PROPANC HEALTH GROUP CORPORATION
576 Swan Street
Richmond, VIC, 3121 Australia
Tel: 61 (0)3 9208 4182
December 13, 2011
VIA EDGAR
Mr. John Krug
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re: Propanc Health Group Corporation
Registration Statement on Form S-1, as amended, initially filed on June 23, 2011
(the “Registration Statement”)
File No: 333-175092
Dear Mr. Krug:
Propanc Health Group Corporation (the “Company”) hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:30 p.m., Thursday, December 15, 2011, or as soon thereafter as practicable.
In connection with our request, we acknowledge the following:
· Should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal laws of the United States.
Thank you in advance for your attention to this matter.
Very truly yours,
Propanc Health Group Corporation
By:
/s/ James Nathanielsz
Name: James Nathanielsz
Title: Chief Executive Officer